Immune-related generalised oedema – A new category of adverse events with immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Immune-related generalised oedema – A new category of adverse events with immune checkpoint inhibitors

Published:2023-01 Issue: Volume:179 Page:28-47
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Velev Maud,Baroudjian Barouyr,Pruvost Roxane,De Martin Eleonora,Laparra Ariane,Babai Samy,Teysseire Sandra,Danlos François-Xavier,Albiges Laurence,Bernigaud Charlotte,Benderra Marc-Antoine,Pradère Pauline,Zaidan Mohamad,Decroisette Chantal,Fallah Fatma,Matergia Gaelle,Lavaud Pernelle,Jantzem Hélène,Atzenhoffer Marina^ORCID,Buyse Véronique,Ammari Samy,Robert Caroline,Champiat Stéphane^ORCID,Messayke Sabine,Marabelle Aurélien,Guettier Catherine,Lebbe Céleste,Lambotte Olivier,Michot Jean-Marie^ORCID

Funder

Novartis

Roche

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline;Brahmer;J Clin Oncol,2018

3. Pericardial toxicities associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database;Ma;Front Pharmacol,2021

4. Late-onset pleural and pericardial effusion as immune-related adverse events after 94 cycles of nivolumab;Sawada;Intern Med,2021

5. Hepatic sinusoidal obstruction syndrome induced by nivolumab in advanced melanoma: a case report;Charvet;Ann Oncol,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Burden of illness of non-hematopoietic stem cell transplant-related hepatic sinusoidal obstruction syndrome: a systematic review;Heliyon;2024-08

2. Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management;Pharmaceutical Medicine;2024-01

3. Multiple drugs;Reactions Weekly;2023-11-18

4. Immune checkpoint inhibitor–associated capillary leak syndrome: A systematic review and a worldwide pharmacovigilance study;Journal of Internal Medicine;2023-04-20